The biofilm production (SLIME) and fluconazole sensitivity of the Candida strains isolated from the mouth flora of newborns and adults

Abstract

Abstract. In this study we planned to investigate the differences of the Candida species in the newborns’ and adults’ mouth flora, their slime production and antimicrobial susceptibility. They were identified with conventional methods (germ tube production) and carbohydrate fermentation characteristics were evaluated by Api 20 C AUX (bioMerieux-France) kits. Stock solution of fluconazole was used for antibiotic susceptibility test. A total of 18 Candida isolates; 14 C. albicans, 2  C. tropicalis, 1 C. kefyr and1 C. lusitaneae were isolated from newborns and 18 Candida strains consisting of 13 C. albicans, 4 C. tropicalis and 1 C. ciferii were isolated from the adults with decayed teeth. Slime production and fluconazole susceptibility tests were performed on these strains. As a result, 4 of 18 (22%) Candida species from newborns and 2 of 18 (11%) strains from adults teeth were observed to be potent slime producer. None of the Candida strains isolated were resistant to fluconazole.

Keywords: Candida, biofilm, fluconazole, mouth flora

Keywords

• Candida, biofilm, fluconazole, mouth flora

Kaynakça

1. Alpoz AR, Hilmioglu S, Isıkgoz, Tasbakan M. The frequency of Candida in mouth in the group of children ages between 7-10 and the relation between dfs, DMFs scores and Candida. Infeksiyon Derg 1999;13: 169-172.
2. Helvaci S, Gedikoglu S, Mistik R. The germ tube test at the diagnosis of Candida. Infeksiyon Derg 1992;6: 141-143.
3. Ak G, Erturan Z, Unur M, Yegenoglu Y. The frequency of yeasts in mouth. Turk Mikrobiyol Cem Derg 1998;28: 107-110.
4. Jacob LS, Flaitz CM, Nichols CM, Hicks MJ. Role of dentinal carious lesions in the pathogenesis of oral candidiasis in HIV infection. J Am Dent Assoc 1998;129: 187-194.
5. Hilmioglu S, Ilkit M, Cavusoglu C, Aydemir S, Tumbay E. The evaluation of slime production of Candida strains with three different methods and its relation between Chrystral Violet Reaction. Infeksiyon Derg 1999;13: 183-186.
6. Sen BH, Safavi KE, Spangberg LS. Colonization of Candida albicans on cleaned human dental hard tissues. Arch Oral Biol 1997;42: 513-520.
7. Yuce A, Yucesoy M, Yulug N. The slime production of Candida strains. Infeksiyon Derg 1996;10: 267-269.
8. Zegarelli DJ. Fungal infections of the oral cavity. Otolaryngol Clin North Am 1993;26: 1069-1089.

9. Arikan S, Rex JH. Antifungal Agents, In: Manual of Clinical Microbiology (Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH) 8thedition ASM Pres, Washington, D.C. 2003, pp:1859-1868.
10. Tanner AC, Milgrom PM, Kent R Jr, et al. The microbiota of young children from tooth and tongue samples. J Dent Res 2002;81: 53-57.
11. Baran JR J, Klauber E, Barczak J, Riederer K, Khatib R. Trends in antifungal susceptibility among Candida spp. Urinary isolates from 1994 and 1998. J Clin Microbiol 2000;38: 870-871.
12. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003;11: 30-6.
13. Donlan R.M., Biofilms and device-associated infections. Emerg Infect Dis 2001;7: 277–281.
14. Yucesoy M, Karaman M. Biofilm production and antifungal susceptibility patterns of Candida species. Mikrobiyol Bul 2004;38: 91-98.
15. Sojakova M, Liptajova D, Borovsky M, Subik J. Fluconazole and itraconazole susceptibility of vaginal yeast isolates from Slovakia. Mycopathologia 2004;157: 163-169.
16. Lattif AA, Banerjee U, Prasad R, et all. Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients. J Clin Microbiol 2004;42: 1260-1262.
17. Yang YL, Cheng HH, Ho YA, Hsiao CF, Lo HJ. Fluconazole resistance rate of Candida species from different regions and hospital types in Taiwan. J Microbiol Immunol Infect 2003;36: 187-191.
18. Gulay Z, Ergon C, Ozkutuk A, Yucesoy M, Bicmen M. Molecular epidemiologic surveillance and antifungal agent sensitivity of Candida albicans isolated from anesthesia intensive care units Mikrobiyol Bült 2002;36: 309-316.
19. Chen YC, Chang SC, Luh KT, Hsieh WC. Stable susceptibility of Candida blood isolates to fluconazole despite increasing use during the past 10 years. J Antimicrob Chemother 2003;5: 71-77.
20. Bedout C, Ayabaca J, Vega R, et al. Evaluation of Candida species' susceptibility to fluconazole with the disk diffusion method. Biomedica 2003;23: 31-37.
21. Sobel JD, Zervos M, Reed BD. Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications. Antimicrob Agents Chemother 2003;47: 34-38.
22. Zer Y, Balci I, Meric G. Identification and antifungal susceptibility of Candida isolated from intensive care unit patients. New Microbiol 2002;25: 489-494.
23. Oon LL, Yeo MG. Fluconazole susceptibility of Candida species in Singapore by disc diffusion test. Ann Acad Med Singapore 2002;31: 497-501.
24. Antunes AG, Pasqualotto AC, Diaz MC, d'Azevedo PA, Severo LC. Candidemia in a Brazilian tertiary care hospital: species distribution and antifungal susceptibility patterns. Rev Inst Med Trop Sao Paulo 2004;46: 239-241.
25. Ito CY, de Paiva Martins CA, Loberto JC, dos Santos SS, Jorge AO. In vitro antifungal susceptibility of Candida spp. isolates from patients with chronic periodontitis and from control patients. Pesqui Odontol Bras 2004;18: 80- 84.
26. Goins RA, Ascher D, Waecker N, Arnold J, Moorefield E. Comparison of fluconazole and nystatin oral suspensions for treatment of oral candidiasis in infants. Pediatr Infect Dis J 2002;21: 1165-1167.
27. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995;39: 2128- 2131.